Results 41 to 50 of about 114,065 (338)

Chronic lymphocytic leukaemia: An immunobiology approach [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2008
B cell chronic lymphocytic leukaemia (CLL) is the most common adult leukaemia that follows an extremely variable clinical course. Several important prognostic parameters defining pathogenic and clinical subgroups of CLL have been identified and validated
Kostareli Efterpi   +4 more
doaj   +1 more source

Inhibition of NF-κB-mediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes pro-survival stimuli to induce apoptosis in chronic lymphocytic leukemia cells [PDF]

open access: yes, 2013
Purpose: Chronic lymphocytic leukemia (CLL) is currently incurable with standard chemotherapeutic agents, highlighting the need for novel therapies. Overcoming proliferative and cytoprotective signals generated within the microenvironment of lymphoid ...
Alison M. McCaig   +14 more
core   +1 more source

Human leukocyte antigens and genetic susceptibility to lymphoma [PDF]

open access: yes, 2015
Familial aggregation, coupled with ethnic variation in incidence, suggests that inherited susceptibility plays a role in the development of lymphoma, and the search for genetic risk factors has highlighted the contribution of the human leukocyte antigen (
Jarrett, R.F., McAulay, K.A.
core   +1 more source

Társult tumorok előfordulása krónikus lymphoid leukaemiában | Occurrence of associated tumours in chronic lymphocytic leukemia [PDF]

open access: yes, 2016
Absztrakt Bevezetés: A krónikus lymphoid leukaemia az egyik leggyakoribb hematológiai rosszindulatú kórkép. Célkitűzés: A 2000–2015 között diagnosztizált krónikus lymphoid leukaemiás betegek ...
Jakó, János   +2 more
core   +1 more source

Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia

open access: yesNature Communications, 2021
The clinical course of chronic lymphocytic leukaemia (CLL) is variable and difficult to predict. Here, the authors conduct a genome wide association study meta-analysis for time to first treatment in CLL patients and report two loci associating with ...
Wei-Yu Lin   +35 more
doaj   +1 more source

A rare case of appendicular skeleton localization in a patient with chronic lymphocytic leukemia successfully treated with salvage radiation therapy [PDF]

open access: yes, 2017
Bone involvements in chronic lymphocytic leukemia (CLL) are considered rare events, and the English-language medical literature describes them only in sporadic case reports. Consequently, robust indications for a rational clinical management are lacking.
Al Sayyad, Said   +12 more
core   +1 more source

Living with chronic lymphocytic leukaemia: patient perspectives from a global online cross-sectional survey on care pathways and impacts on quality of life

open access: yesFrontiers in Hematology
BackgroundChronic Lymphocytic Leukaemia (CLL) is a slow-progressing condition often managed through active monitoring (“watch and wait”) strategies, which can lead to uncertainty for patients about prognosis, symptom management, and immunity-related ...
Kathryn Huntley   +6 more
doaj   +1 more source

The Occurrence of Richter’s Syndrome during Treatment with Obinutuzumab and Chlorambucil

open access: yesCase Reports in Hematology, 2020
Chronic lymphocytic leukaemia is a slow-growing leukaemia of developing B-lymphocytes, which may transform to an aggressive lymphoma known as Richter’s syndrome. While Richter’s syndrome can present in untreated or relapsed-refractory cases, it may occur
Teng Fong Ng   +4 more
doaj   +1 more source

Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial.

open access: yesThe Lancet Oncology
BACKGROUND Most patients with chronic lymphocytic leukaemia progress after treatment or retreatment with targeted therapy or chemoimmunotherapy and have limited subsequent treatment options.
A. Kater   +26 more
semanticscholar   +1 more source

Impact of leukemia subtype and demographics on patient quality of life in 76 countries: a cross-sectional study

open access: yesFrontiers in Hematology
BackgroundDisease-specific factors associated with decreased quality of life (QoL) in patients with leukemia have not been studied in a large-scale, global, observational study.MethodsThis cross-sectional study used the validated Hematological Malignancy
Sam Salek   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy